Literature DB >> 9500447

Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells.

K Shibata1, F Kikkawa, A Nawa, A A Thant, K Naruse, S Mizutani, M Hamaguchi.   

Abstract

Cell adhesion to the extracellular matrix appears to trigger a cascade of intracellular signalings. We have shown previously that treatment of ovarian cancer cells with peritoneal conditioned medium or purified fibronectin (FN) activated matrix metalloproteinase 9 secretion and, thereby, cancer cell invasion. By use of antisense oligonucleotides to focal adhesion kinase (FAK) and a dominant-negative mutant of ras (S17Nras), we found that both FAK and c-Ras were required for the activation of matrix metalloproteinase 9 secretion by FN. In addition, both antisense oligonucleotides to FAK and S17Nras inhibited mitogen-activated protein kinase activation by FN treatment, suggesting the involvement of mitogen-activated protein kinase in the FN-dependent signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500447

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  Escherichia coli cytotoxic necrotizing factor 1 inhibits intestinal epithelial wound healing in vitro after mechanical injury.

Authors:  Patrick Brest; Laurent Turchi; Gaëlle Le'Negrate; Frédérick Berto; Chimène Moreilhon; Bernard Mari; Gilles Ponzio; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.

Authors:  Lakshmi Arivazhagan; Ganesh Venkatraman; Suresh K Rayala
Journal:  Mol Cell Biol       Date:  2019-03-19       Impact factor: 4.272

3.  Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

Authors:  Jyotsnabaran Halder; Aparna A Kamat; Charles N Landen; Liz Y Han; Susan K Lutgendorf; Yvonne G Lin; William M Merritt; Nicholas B Jennings; Arturo Chavez-Reyes; Robert L Coleman; David M Gershenson; Rosemarie Schmandt; Steven W Cole; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

4.  Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.

Authors:  Bin Liang; Shan Wang; Xue-Guang Zhu; Yong-Xiang Yu; Zhi-Rong Cui; You-Zhi Yu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.

Authors:  A A Thant; A Nawa; F Kikkawa; Y Ichigotani; Y Zhang; T T Sein; A R Amin; M Hamaguchi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 6.  Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis.

Authors:  Xiaofeng Zhao; Jun-Lin Guan
Journal:  Adv Drug Deliv Rev       Date:  2010-11-29       Impact factor: 15.470

7.  Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.

Authors:  X N Meng; Y Jin; Y Yu; J Bai; G Y Liu; J Zhu; Y Z Zhao; Z Wang; F Chen; K-Y Lee; S B Fu
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

8.  Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Authors:  Anil K Sood; Jeremy E Coffin; Galen B Schneider; Mavis S Fletcher; Barry R DeYoung; Lynn M Gruman; David M Gershenson; Michael D Schaller; Mary J C Hendrix
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 9.  Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis.

Authors:  Ming Luo; Jun-Lin Guan
Journal:  Cancer Lett       Date:  2009-07-29       Impact factor: 8.679

10.  Rab5 activation promotes focal adhesion disassembly, migration and invasiveness in tumor cells.

Authors:  Pablo Mendoza; Rina Ortiz; Jorge Díaz; Andrew F G Quest; Lisette Leyton; Dwayne Stupack; Vicente A Torres
Journal:  J Cell Sci       Date:  2013-06-26       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.